Track record · closed signal

UiPath Inc. (PATH) — closed signal from October 20, 2025

Partial Published before the outcome was known, scored automatically when the window closed on January 18, 2026.

Predicted vs. what happened

PATH price · publication thesis → realized outcomesplit-adjusted
$15.88 Published $20.96 Target $14.34 Window close $19.84 Peak
$15.50 – $16.20Entry zone — fair-value band
$15.88Published — price the day we called it
$20.96Target — the price the thesis aimed for
$19.84Peak — highest point inside the window, not a realized return
$14.34Window close — end-of-window price, context only

What happened

Partial

Reached 78% of the predicted growth at its peak, without hitting the target.

Peak price
$19.84
peak on December 8, 2025 — not a realized return
Peak gain
+24.9%
peak, from the publication price
Window close
$14.34
end-of-window price, context only
Days to target
Window
October 20, 2025 – January 18, 2026

The thesis — published October 20, 2025

Predicted growth
+32%
over the measurement window
Target price
$20.96
the price the thesis aimed for
Entry zone
$15.50 – $16.20
the fair-value band we waited for
Price at publication
$15.88
published October 20, 2025
Confidence
70%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

UiPath builds AI tools that automate office work. New Maestro features and testing expand what the platform can do. With about $1.4B in cash and no debt, the company has room to execute. Lately, more buyers than usual and a rising recent average price point to near-term strength. After a fast rise, waiting for small dips could set up a 1-3 month move if volume stays high.

Primary drivers

  • Regular AI feature releases like Maestro expand what the software can do.
  • More buyers than usual and steady upward price action support momentum.
  • Large cash balance and no debt give room to invest and improve the product.
  • More companies want to automate routine work, lifting long-term demand.

How it played out

PATH: target missed after a 24.9% peak gain

Lyra published PATH at $15.88 on 2025-10-20 for a short-term window through 2026-01-18. The thesis expected 32% growth. It pointed to regular artificial-intelligence feature releases such as Maestro, stronger buyer interest, steady upward price action, a large cash balance with no debt, and demand for routine-work automation.

Inside the window, PATH rose to $19.84 on 2025-12-08, a 24.9% peak gain. That peak stayed below the $20.96 target. It never got there. By 2026-01-18, PATH ended at $14.34. The thesis partly played out on the rise, but missed the target and faded by the close.

What happened during the window

On 2025-12-05, ITPro reported that UiPath partnered with Veeva to streamline application testing and validation for life sciences customers.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.